| Capecitabine (X) combined with trastuzumab (H) as first-line therapy in patients (pts) with HER2-overexpressing metastatic breast cancer (MBC) | |
| Xu, Ligong; Song, Santai; Zhu, Jianxin; Luo, Rongcheng; Li, Lejing; Jiao, Shunchang; Pan, Hongming; Tao, Ming; Su, Yongqian; Liu, Duanqi | |
| 2004 | |
| 卷号 | 15 |
| 会议录 | ANNALS OF ONCOLOGY
 |
| 语种 | 英语 |
| URL标识 | 查看原文 |
| ISSN号 | 0923-7534 |
| 内容类型 | 会议论文 |
| URI标识 | http://www.corc.org.cn/handle/1471x/5649493 |
| 专题 | 复旦大学上海医学院 |
| 推荐引用方式 GB/T 7714 | Xu, Ligong,Song, Santai,Zhu, Jianxin,et al. Capecitabine (X) combined with trastuzumab (H) as first-line therapy in patients (pts) with HER2-overexpressing metastatic breast cancer (MBC)[C]. 见:. |
| 个性服务 |
| 查看访问统计 |
| 相关权益政策 |
| 暂无数据 |
| 收藏/分享 |
除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。
修改评论